|
15.03.2016 12:06:21
|
DGAP-News: M1 Beauty AG
DGAP-News: M1 Beauty AG: 2015: Preliminary IFRS results, sales increase of 49 % to EUR 34.3 million, 38 % improvement in the operating result (EBIT) to EUR 6.9 million; investments in the expansion of hospital capacities and outpatient services
In the financial year 2015 M1 Beauty AG, Berlin (ISIN: DEA0STSQ8), achieved IFRS Group sales of EUR 34.3 million (previous year: EUR 23.0 million) and an operating result (EBIT) of EUR 6.9 million (previous year: EUR 5.0 million).
"The M1 Group has exceeded sales of the prior year by 49 %. Outpatient services were expanded. The capacities will be increased in 2016 as well, so that we can be confident for the further development of sales and earnings for the whole year 2016", says Patrick Brenske, Member of the Management Board of M1 Beauty AG.
About M1 Beauty AG:
M1 Beauty AG has specialised in the medical beauty market. The aim is to offer an affordable access to aesthetic medicine and plastic surgery with products and services "Made in Germany".
Besides a comprehensive offer of medical aesthetic treatments, the group develops and sells pharmaceutical and medical products and services as well as medical devices for the aesthetic medicine and plastic surgery.
M1 Beauty AG is listed in the Entry Standard (Open Market) on the Frankfurt Stock Exchange. Key figures for the share of M1 Beauty AG: Subscribed capital: EUR 15,000,000 Listed shares: bearer shares ISIN: DE000A0STSQ8 WKN: A0STSQ Stock symbol: M12
Contact: M1 Beauty AG Grünauer Straße 5 D-12557 Berlin Phone: +49 (0)30 887 086 225 Fax: +49 (0)30 887 086 228 E-Mail: ir@m1-beauty.de Web: www.m1-beauty-ag.de
---------------------------------------------------------------------------
15.03.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
445227 15.03.2016
DGAP-News: M1 Beauty AG / Key word(s): Preliminary Results
M1 Beauty AG: 2015: Preliminary IFRS results, sales increase of 49 % to EUR
34.3 million, 38 % improvement in the operating result (EBIT) to EUR 6.9
million; investments in the expansion of hospital capacities and outpatient
services
15.03.2016 / 12:06
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
2015: Preliminary IFRS results, sales increase of 49 % to EUR 34.3 million,
38 % improvement in the operating result (EBIT) to EUR 6.9 million;
investments in the expansion of hospital capacities and outpatient
services
In the financial year 2015 M1 Beauty AG, Berlin (ISIN: DEA0STSQ8), achieved IFRS Group sales of EUR 34.3 million (previous year: EUR 23.0 million) and an operating result (EBIT) of EUR 6.9 million (previous year: EUR 5.0 million).
"The M1 Group has exceeded sales of the prior year by 49 %. Outpatient services were expanded. The capacities will be increased in 2016 as well, so that we can be confident for the further development of sales and earnings for the whole year 2016", says Patrick Brenske, Member of the Management Board of M1 Beauty AG.
About M1 Beauty AG:
M1 Beauty AG has specialised in the medical beauty market. The aim is to offer an affordable access to aesthetic medicine and plastic surgery with products and services "Made in Germany".
Besides a comprehensive offer of medical aesthetic treatments, the group develops and sells pharmaceutical and medical products and services as well as medical devices for the aesthetic medicine and plastic surgery.
M1 Beauty AG is listed in the Entry Standard (Open Market) on the Frankfurt Stock Exchange. Key figures for the share of M1 Beauty AG: Subscribed capital: EUR 15,000,000 Listed shares: bearer shares ISIN: DE000A0STSQ8 WKN: A0STSQ Stock symbol: M12
Contact: M1 Beauty AG Grünauer Straße 5 D-12557 Berlin Phone: +49 (0)30 887 086 225 Fax: +49 (0)30 887 086 228 E-Mail: ir@m1-beauty.de Web: www.m1-beauty-ag.de
---------------------------------------------------------------------------
15.03.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
445227 15.03.2016
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu M1 Kliniken AGmehr Nachrichten
|
19.11.24 |
EQS-News: M1 Kliniken AG increases operating profit (EBIT) by 71% in the first nine months of 2024 and confirms medium-term targets (EQS Group) | |
|
19.11.24 |
EQS-News: M1 Kliniken AG steigert operativen Gewinn (EBIT) um 71 % in den ersten neun Monaten 2024 und bestätigt Mittelfristziele (EQS Group) | |
|
03.09.24 |
EQS-News: Operativer Gewinn (EBIT) fast verdoppelt: M1 Kliniken AG wächst auch in H1 2024 deutlich (EQS Group) | |
|
03.09.24 |
EQS-News: Operating Profit (EBIT) almost doubled: M1 Kliniken AG also grows significantly in the first half of 2024 (EQS Group) | |
|
21.06.24 |
EQS-News: M1 Kliniken AG: Management Board confirms growth targets (EQS Group) | |
|
21.06.24 |
EQS-News: M1 Kliniken AG: Vorstand bestätigt Wachstumsziele (EQS Group) | |
|
20.06.24 |
EQS-DD: M1 Kliniken AG: Attila Strauss, sell (EQS Group) | |
|
20.06.24 |
EQS-DD: M1 Kliniken AG: Attila Strauss, Verkauf (EQS Group) |
Analysen zu M1 Kliniken AGmehr Analysen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.